FOLFOXIRI plus bevacizumab versus FOLFOX plus bevacizumab for patients with metastatic colorectal cancer and ≥3 circulating tumour cells: the randomised phase III VISNÚ-1 trial
Aranda, Enrique, Viéitez, Jose Maria, Gómez-España, Auxiliadora, Gil Calle, Silvia, Salud-Salvia, Antonieta, Graña, Begoña, Garcia-Alfonso, Pilar, Rivera, Fernando, Quintero-Aldana, Guillermo Alfonso, Reina-Zoilo, Juan José, González-Flores, Encarnación, Salgado Fernández, Mercedes, Guillén‑Ponce, Carmen, Garcia-Carbonero, Rocio, Safont, María José, La Casta Munoa, Adelaida, García-Paredes, Beatriz, López López, Rafael, Sastre, Javier, Díaz-Rubio, Eduardo
Published in ESMO open (01.01.2020)
Published in ESMO open (01.01.2020)
Get full text
Journal Article
Immune Microenvironment in Colorectal Cancer : A New Hallmark to Change Old Paradigms
Henao Carrasco, Fernando, Nogales Fernández, Esteban, de la Cruz-Merino, Luis, Pulido, Enrique Grande, Codes Manuel de Villena, Manuel, Reina Zoilo, Juan José, Vicente Baz, David
Published in Clinical & developmental immunology (01.01.2011)
Published in Clinical & developmental immunology (01.01.2011)
Get full text
Journal Article
Real-world dosing patterns of regorafenib for patients with metastatic colorectal cancer in Spain: the RE-SEARCH study
López Muñoz, Ana María, González Flores, Encarnación, Carral Maseda, Alberto, Pimentel Cáceres, Paola, Afonso Gómez, Ruth, López López, Carlos, Jimeno Maté, Raquel, Reina Zoilo, Juan José, Castañón López, Carmen, Salgado Fernández, Mercedes, Aparicio Urtasun, Jorge, Asensio Martínez, Elena, Martín Gómez, Teresa
Published in Clinical & translational oncology (11.08.2024)
Published in Clinical & translational oncology (11.08.2024)
Get full text
Journal Article
Real-world study on microsatellite instability and mismatch repair deficiency testing patterns among patients with metastatic colorectal cancer in Spain
Garcia-Carbonero, Rocio, González Astorga, Beatriz, Vidal Tocino, Rosario, Contreras Toledo, Débora, Pericay, Carles, Fernández Montes, Ana, Falcó, Esther, González Cordero, Marta, Reina Zoilo, Juan José, Alonso, Vicente, Rodríguez Salas, Nuria, Gil-Raga, Mireia, Santos, Cristina, Páez, David, Anton-Pascual, Beatriz, Aguilar, Fernando, Morales, Pilar
Published in Clinical & translational oncology (01.04.2024)
Published in Clinical & translational oncology (01.04.2024)
Get full text
Journal Article
Delphi consensus on the follow-up of cancer patients with breakthrough pain under opioid treatment
Gonzalez Larriba, Jose Luis, Cayuela, Diego, Fernandez Calvo, Ovidio, Garcera, Salvador, Molina, Raquel, Reina-Zoilo, Juan José, Guillem, Vicente, Camps, Carlos, Feyjoo, Margarita
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Randomized phase III study comparing FOLFOX + bevacizumab versus folfoxiri + bevacizumab (BEV) as 1st line treatment in patients with metastatic colorectal cancer (mCRC) with ≥3 baseline circulating tumor cells (bCTCs)
Sastre, Javier, Vieitez, Jose María, Gomez-España, Maria Auxilidora, Gil Calle, Silvia, Salud Salvia, Antonieta, Suárez, Begoña Graña, Garcia-Alfonso, Pilar, Martinez de Castro, Eva, Quintero Aldana, Guillermo Alfonso, Reina-Zoilo, Juan José, González Flores, Encarnación, Fernández, Mercedes Salgado, Guillen, Carmen, Garcia-Carbonero, Rocio, Safont, Maria Jose, La Casta Munoa, Adelaida, García de Paredes, Beatriz, Lopez, Rafael, Aranda, Enrique, Díaz-Rubio, Eduardo
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Randomized phase II study on the influence of BRAF and PIK3CA mutations on the efficacy of FOLFIRI plus bevacizumab (Bev) or cetuximab (Cet), as first line therapy of patients (pts) with RAS wild-type metastatic colorectal carcinoma (mCRC) and <3 baseline circulating tumor cells (bCTCs)
Aranda, Enrique, Garcia-Alfonso, Pilar, Vieitez, Jose María, Ortiz, Maria Jose, López-López, Carlos, Reina-Zoilo, Juan José, Salud Salvia, Antonieta, Quintero Aldana, Guillermo Alfonso, Robles, Luis, Safont, Maria Jose, La Casta Munoa, Adelaida, Alés, Inmaculada, Polo Marques, Eduardo, Gallego Plazas, Javier, García de Paredes, Beatriz, Lopez, Rafael, Mónica, Guillot, Valladares-Ayerbes, Manuel, Sastre, Javier, Díaz-Rubio, Eduardo
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Delphi Consensus on the Follow-up of Cancer Patients with Breakthrough Pain Under Opioid Treatment
Larriba González, José Luis, Cayuela López, Diego, Fernández Calvo, Ovidio, Garcerá Juan, Salvador, Molina Villaverde, Raquel, Reina Zoilo, Juan José, Guillém, Vicente, Camps, Carlos, Feyjóo, Margarita
Published in SN comprehensive clinical medicine (01.11.2019)
Published in SN comprehensive clinical medicine (01.11.2019)
Get full text
Journal Article
Immune Microenvironment in Colorectal Cancer: A New Hallmark to Change Old Paradigms
Pulido, Enrique Grande, Reina Zoilo, Juan José, Nogales Fernández, Esteban, Vicente Baz, David, Henao Carrasco, Fernando, de la Cruz-Merino, Luis, Codes Manuel de Villena, Manuel
Published in Journal of immunology research (2010)
Published in Journal of immunology research (2010)
Get full text
Journal Article
Trybeca-1: A randomized, phase 3 study of eryaspase in combination with chemotherapy versus chemotherapy alone as second-line treatment in patients with advanced pancreatic adenocarcinoma (NCT03665441)
Hammel, Pascal, El-Hariry, Iman, Macarulla, Teresa, Garcia-Carbonero, Rocio, Metges, Jean-Philippe, Bouché, Olivier, Portales, Fabienne, Pazo Cid, Roberto A., Mineur, Laurent, Cubillo Gracian, Antonio Manuel, Trouilloud, Isabelle, Guimbaud, Rosine, Tougeron, David, Reina Zoilo, Juan Jose, Feliu, Jaime, Sauri, Tamara, Fountzilas, Christos, Kay, Richard, Youssoufian, Hagop, Hidalgo, Manuel
Published in Journal of clinical oncology (01.02.2022)
Published in Journal of clinical oncology (01.02.2022)
Get full text
Journal Article